Use of BEPREVE (Bepotastine Besilate Ophthalmic Solution) 1.5% for Allergic Conjunctivitis and Contact Lenses
Condition(s):Allergic ConjunctivitisLast Updated:April 19, 2011Unknown status
Hide Studies Not Open or Pending
Condition(s):Allergic ConjunctivitisLast Updated:April 19, 2011Unknown status
Condition(s):Histamine Responsive Allergy PatientsLast Updated:July 8, 2010Completed
Condition(s):Perennial Allergic RhinitisLast Updated:April 8, 2016Completed
Condition(s):Allergic ConjunctivitisLast Updated:August 6, 2019Completed
Condition(s):Perennial Allergic RhinitisLast Updated:December 15, 2015Completed
Condition(s):Allergic ConjunctivitisLast Updated:December 15, 2022Completed
Condition(s):Eye AllergiesLast Updated:January 9, 2014Completed
Condition(s):Seasonal Allergic RhinitisLast Updated:October 5, 2020Completed
Condition(s):Dermatitis; AtopicLast Updated:May 25, 2018Completed
Condition(s):Conjunctivitis, AllergicLast Updated:February 15, 2013Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.